Honghai Dai

528 total citations
14 papers, 355 citations indexed

About

Honghai Dai is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Honghai Dai has authored 14 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in Honghai Dai's work include Lung Cancer Treatments and Mutations (6 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Honghai Dai is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Honghai Dai collaborates with scholars based in China. Honghai Dai's co-authors include Zhe Yang, Alei Feng, Qiang Wen, Lühua Wang, Zongmei Zhou, Jun Liang, Zhouguang Hui, Weibo Yin, Qiang Li and Qinfu Feng and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, The Oncologist and Journal of Thoracic Oncology.

In The Last Decade

Honghai Dai

13 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Honghai Dai China	11	236	167	136	43	42	14	355
Masahiko Higashiyama Japan	8	350 1.5×	77 0.5×	107 0.8×	60 1.4×	51 1.2×	8	447
C. Zwarthoed France	5	114 0.5×	175 1.0×	93 0.7×	44 1.0×	56 1.3×	12	329
Dori Giroux United States	8	420 1.8×	150 0.9×	171 1.3×	56 1.3×	118 2.8×	9	618
Emine Göknur Işık Türkiye	10	118 0.5×	128 0.8×	169 1.2×	66 1.5×	51 1.2×	41	313
Hai‐Qiang Mai China	11	87 0.4×	58 0.3×	135 1.0×	82 1.9×	38 0.9×	23	293
Miho Kawashima Japan	9	113 0.5×	107 0.6×	54 0.4×	37 0.9×	34 0.8×	33	293
M. Neubauer United States	10	182 0.8×	30 0.2×	196 1.4×	31 0.7×	18 0.4×	20	304
Yuhui Liu China	9	142 0.6×	191 1.1×	102 0.8×	36 0.8×	51 1.2×	27	324
Denise N. Gansen United States	7	66 0.3×	49 0.3×	67 0.5×	51 1.2×	37 0.9×	8	272
Catherine Dubos‐Arvis France	8	348 1.5×	104 0.6×	310 2.3×	36 0.8×	57 1.4×	11	476

Countries citing papers authored by Honghai Dai

Since Specialization

Citations

This map shows the geographic impact of Honghai Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honghai Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honghai Dai more than expected).

Fields of papers citing papers by Honghai Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honghai Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honghai Dai. The network helps show where Honghai Dai may publish in the future.

Co-authorship network of co-authors of Honghai Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Honghai Dai. A scholar is included among the top collaborators of Honghai Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honghai Dai. Honghai Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wang, Haohua, Xiaoli Sun, Xuezhang Duan, et al.. (2025). Maintaining First-Line Therapy Plus Radiation Therapy May Prolong Progression-Free Survival and Delay Second-Line Therapy for Oligoprogressive Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 122(2). 325–338. 1 indexed citations

Sun, Xiaolin, Honghai Dai, Qiang Li, et al.. (2022). CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases. Frontiers in Genetics. 13. 862264–862264. 7 indexed citations

Dai, Honghai, Yanjun Wei, Yunxia Liu, et al.. (2022). Pathway-Based Analysis Revealed the Role of Keap1-Nrf2 Pathway and PI3K-Akt Pathway in Chinese Esophageal Squamous Cell Carcinoma Patients With Definitive Chemoradiotherapy. Frontiers in Genetics. 12. 799663–799663. 11 indexed citations

Wen, Qiang, Zhe Yang, Honghai Dai, Alei Feng, & Qiang Li. (2021). Radiomics Study for Predicting the Expression of PD-L1 and Tumor Mutation Burden in Non-Small Cell Lung Cancer Based on CT Images and Clinicopathological Features. Frontiers in Oncology. 11. 620246–620246. 54 indexed citations

Wen, Qiang, Zhe Yang, Jian Zhu, et al.. (2020). <p>Pretreatment CT-Based Radiomics Signature as a Potential Imaging Biomarker for Predicting the Expression of PD-L1 and CD8+TILs in ESCC</p>. OncoTargets and Therapy. Volume 13. 12003–12013. 37 indexed citations

Dai, Honghai, Yang Shao, Xiaoling Tong, et al.. (2019). YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma. Cancer Medicine. 9(5). 1628–1637. 16 indexed citations

Ding, Xiao, Zhouguang Hui, Honghai Dai, et al.. (2016). A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 11(9). 1565–1573. 36 indexed citations

Yang, Zhe, et al.. (2016). Clinical observation of gene expression-guided chemoradiation therapy for nonsurgical esophageal squamous cell carcinoma patients: a retrospective analysis of 36 cases. OncoTargets and Therapy. Volume 9. 4561–4568. 1 indexed citations

Zhang, Qiong, Honghai Dai, Hongyun Dong, et al.. (2014). EGFR mutations and clinical outcomes of chemotherapy for advanced non-small cell lung cancer: A meta-analysis. Lung Cancer. 85(3). 339–345. 19 indexed citations

10.

Hui, Zhouguang, Honghai Dai, Jun Liang, et al.. (2014). Selection of proper candidates with resected pathological stage IIIA‐N2 non‐small cell lung cancer for postoperative radiotherapy. Thoracic Cancer. 6(3). 346–353. 25 indexed citations

11.

Ding, Xiao, Honghai Dai, Zhouguang Hui, et al.. (2012). Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer. Radiation Oncology. 7(1). 119–119. 29 indexed citations

12.

Dai, Honghai, Zhouguang Hui, Wei Ji, et al.. (2011). Postoperative Radiotherapy for Resected Pathological Stage IIIA–N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution. The Oncologist. 16(5). 641–650. 65 indexed citations

13.

Yu, Huiming, Yunfang Liu, Zhe Yang, et al.. (2010). TLR7 regulates dendritic cell-dependent B-cell responses through BlyS in immune thrombocytopenic purpura. European Journal Of Haematology. 86(1). 67–74. 29 indexed citations

14.

Cheng, C. H., Long Meng, Jiajun Du, et al.. (2007). 18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer. Chinese Medical Journal. 120(2). 125–131. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact